IOT.V 0.25 0.00 0.00%

Investor Relations

Committed to Growth and Innovation

Innovotech Inc. is dedicated to delivering value to our investors through innovative technologies and a robust portfolio of services in product development and research.

Company Overview

As a diversified technology firm, Innovotech Inc. operates across several key sectors, including the production and sale of laboratory consumables, as well as the development of cutting-edge solutions for various applications. Our operations are streamlined through specialized subsidiaries: Innovotech Labs Corporation (ILC), recognized for its established antimicrobial contract services and trusted by numerous global medical device companies, and Keystone Labs (KLI), a boutique analytical and microbiology service provider catering to clients in the pharmaceutical and biotechnology sectors.

Additionally, Innovotech holds a 60% interest in NouLife Sciences Inc. (NSI), which specializes in valuable intellectual property related to linked antioxidant molecules utilized in skincare and medical treatments. As a publicly listed company on the TSX Venture Exchange under the symbol IOT, we prioritize transparency with our stakeholders while actively pursuing growth and innovation in our field.

Financial Statements

news REleases

Innovotech Inc. Strengthens Executive Team and Announces New Edmonton Facility Lease

Innovotech Inc. Announces Intention to Apply for Trading on the OTCQB Venture Market

January 23 2026 Innovotech Inc. Presenting at DealFlow Conference

Innovotech Inc. Announces Amalgamation of Subsidiaries to Streamline Operations

IOT announcing closing of Convertible Debenture

Innovotech Inc. (IOT) News Release for Q3 2025

Latest Financial Results

We provide timely updates on our financial performance to ensure transparency and keep our investors well-informed of our progress.

Stock Information

Innovotech Inc. trades on the TSX Venture Exchange under the symbol IOT, offering investors an opportunity to participate in our growth story.

Leadership

Our experienced leadership team drives Innovotech’s strategic vision, leveraging their expertise in microbiology, technology development, and business growth to create shareholder value.